✦ LIBER ✦

25PD CIRCULATING MICRO-RNA PROFILING IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON SMALL-CELL LUNG CANCER RECEIVING BEVACIZUMAB/ERLOTINIB FIRST-LINE TREATMENT FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY AT DISEASE PROGRESSION (SAKK 19/05)

✍ Scribed by Joerger, M.; Baty, F.; Stahel, R.A.; Betticher, D.; von Moos, R.; Pless, M.; Gautschi, O.; Brauchli, P.; Zappa, F.; Brutsche, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating microRNA profiling in patien

✍ Joerger, M.; Baty, F.; Früh, M.; Droege, C.; Stahel, R.A.; Betticher, D.C.; von 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 663 KB

Bevacizumab and erlotinib (BE) first-lin

✍ Zappa, Francesco; Droege, Cornelia; Betticher, Daniel; von Moos, Roger; Bubendor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 325 KB

9147 Bevacizumab and erlotinib as first-

✍ Zappa, F.; Droege, C.; Betticher, D.; von Moos, R.; Ochsenbein, A.; Stahel, R.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Randomized Phase IIIb Trial Evaluating t

✍ Cesare Gridelli; Jaafar Bennouna; Javier de Castro; Anne-Marie C. Dingemans; Fra 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 268 KB